Global Prostate Cancer Molecular Diagnostics Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 178929
  • calendar_today Published On: Mar, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Prostate Cancer Molecular Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Prostate Cancer Molecular Diagnostics size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Prostate Cancer Molecular Diagnostics market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Prostate Cancer Molecular Diagnostics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

PCR

FISH

DNA Sequencing

Gene Chip

Market segment by Application, can be divided into

Clinical Diagnosis

Drug Screening

Research

Market segment by players, this report covers

Qiagen

Foundationmedicine

Genetech

Gpmedical

Premed

Berryoncology

Gene+

Annoroad

Topgen

Geneis

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Prostate Cancer Molecular Diagnostics

1.2 Classification of Prostate Cancer Molecular Diagnostics by Type

1.2.1 Overview: Global Prostate Cancer Molecular Diagnostics Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Prostate Cancer Molecular Diagnostics Revenue Market Share by Type in 2020

1.2.3 PCR

1.2.4 FISH

1.2.5 DNA Sequencing

1.2.6 Gene Chip

1.3 Global Prostate Cancer Molecular Diagnostics Market by Application

1.3.1 Overview: Global Prostate Cancer Molecular Diagnostics Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Clinical Diagnosis

1.3.3 Drug Screening

1.3.4 Research

1.4 Global Prostate Cancer Molecular Diagnostics Market Size & Forecast

1.5 Global Prostate Cancer Molecular Diagnostics Market Size and Forecast by Region

1.5.1 Global Prostate Cancer Molecular Diagnostics Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Prostate Cancer Molecular Diagnostics Market Size by Region, (2016-2021)

1.5.3 North America Prostate Cancer Molecular Diagnostics Market Size and Prospect (2016-2026)

1.5.4 Europe Prostate Cancer Molecular Diagnostics Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Prostate Cancer Molecular Diagnostics Market Size and Prospect (2016-2026)

1.5.6 South America Prostate Cancer Molecular Diagnostics Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Prostate Cancer Molecular Diagnostics Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Prostate Cancer Molecular Diagnostics Market Drivers

1.6.2 Prostate Cancer Molecular Diagnostics Market Restraints

1.6.3 Prostate Cancer Molecular Diagnostics Trends Analysis

2 Company Profiles

2.1 Qiagen

2.1.1 Qiagen Details

2.1.2 Qiagen Major Business

2.1.3 Qiagen Prostate Cancer Molecular Diagnostics Product and Solutions

2.1.4 Qiagen Prostate Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Qiagen Recent Developments and Future Plans

2.2 Foundationmedicine

2.2.1 Foundationmedicine Details

2.2.2 Foundationmedicine Major Business

2.2.3 Foundationmedicine Prostate Cancer Molecular Diagnostics Product and Solutions

2.2.4 Foundationmedicine Prostate Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Foundationmedicine Recent Developments and Future Plans

2.3 Genetech

2.3.1 Genetech Details

2.3.2 Genetech Major Business

2.3.3 Genetech Prostate Cancer Molecular Diagnostics Product and Solutions

2.3.4 Genetech Prostate Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Genetech Recent Developments and Future Plans

2.4 Gpmedical

2.4.1 Gpmedical Details

2.4.2 Gpmedical Major Business

2.4.3 Gpmedical Prostate Cancer Molecular Diagnostics Product and Solutions

2.4.4 Gpmedical Prostate Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Gpmedical Recent Developments and Future Plans

2.5 Premed

2.5.1 Premed Details

2.5.2 Premed Major Business

2.5.3 Premed Prostate Cancer Molecular Diagnostics Product and Solutions

2.5.4 Premed Prostate Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Premed Recent Developments and Future Plans

2.6 Berryoncology

2.6.1 Berryoncology Details

2.6.2 Berryoncology Major Business

2.6.3 Berryoncology Prostate Cancer Molecular Diagnostics Product and Solutions

2.6.4 Berryoncology Prostate Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Berryoncology Recent Developments and Future Plans

2.7 Gene+

2.7.1 Gene+ Details

2.7.2 Gene+ Major Business

2.7.3 Gene+ Prostate Cancer Molecular Diagnostics Product and Solutions

2.7.4 Gene+ Prostate Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Gene+ Recent Developments and Future Plans

2.8 Annoroad

2.8.1 Annoroad Details

2.8.2 Annoroad Major Business

2.8.3 Annoroad Prostate Cancer Molecular Diagnostics Product and Solutions

2.8.4 Annoroad Prostate Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Annoroad Recent Developments and Future Plans

2.9 Topgen

2.9.1 Topgen Details

2.9.2 Topgen Major Business

2.9.3 Topgen Prostate Cancer Molecular Diagnostics Product and Solutions

2.9.4 Topgen Prostate Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Topgen Recent Developments and Future Plans

2.10 Geneis

2.10.1 Geneis Details

2.10.2 Geneis Major Business

2.10.3 Geneis Prostate Cancer Molecular Diagnostics Product and Solutions

2.10.4 Geneis Prostate Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Geneis Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Prostate Cancer Molecular Diagnostics Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Prostate Cancer Molecular Diagnostics Players Market Share

3.2.2 Top 10 Prostate Cancer Molecular Diagnostics Players Market Share

3.2.3 Market Competition Trend

3.3 Prostate Cancer Molecular Diagnostics Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Prostate Cancer Molecular Diagnostics Revenue and Market Share by Type (2016-2021)

4.2 Global Prostate Cancer Molecular Diagnostics Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Prostate Cancer Molecular Diagnostics Revenue Market Share by Application (2016-2021)

5.2 Prostate Cancer Molecular Diagnostics Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Prostate Cancer Molecular Diagnostics Revenue by Type (2016-2026)

6.2 North America Prostate Cancer Molecular Diagnostics Revenue by Application (2016-2026)

6.3 North America Prostate Cancer Molecular Diagnostics Market Size by Country

6.3.1 North America Prostate Cancer Molecular Diagnostics Revenue by Country (2016-2026)

6.3.2 United States Prostate Cancer Molecular Diagnostics Market Size and Forecast (2016-2026)

6.3.3 Canada Prostate Cancer Molecular Diagnostics Market Size and Forecast (2016-2026)

6.3.4 Mexico Prostate Cancer Molecular Diagnostics Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Prostate Cancer Molecular Diagnostics Revenue by Type (2016-2026)

7.2 Europe Prostate Cancer Molecular Diagnostics Revenue by Application (2016-2026)

7.3 Europe Prostate Cancer Molecular Diagnostics Market Size by Country

7.3.1 Europe Prostate Cancer Molecular Diagnostics Revenue by Country (2016-2026)

7.3.2 Germany Prostate Cancer Molecular Diagnostics Market Size and Forecast (2016-2026)

7.3.3 France Prostate Cancer Molecular Diagnostics Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Prostate Cancer Molecular Diagnostics Market Size and Forecast (2016-2026)

7.3.5 Russia Prostate Cancer Molecular Diagnostics Market Size and Forecast (2016-2026)

7.3.6 Italy Prostate Cancer Molecular Diagnostics Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Prostate Cancer Molecular Diagnostics Revenue by Type (2016-2026)

8.2 Asia-Pacific Prostate Cancer Molecular Diagnostics Revenue by Application (2016-2026)

8.3 Asia-Pacific Prostate Cancer Molecular Diagnostics Market Size by Region

8.3.1 Asia-Pacific Prostate Cancer Molecular Diagnostics Revenue by Region (2016-2026)

8.3.2 China Prostate Cancer Molecular Diagnostics Market Size and Forecast (2016-2026)

8.3.3 Japan Prostate Cancer Molecular Diagnostics Market Size and Forecast (2016-2026)

8.3.4 South Korea Prostate Cancer Molecular Diagnostics Market Size and Forecast (2016-2026)

8.3.5 India Prostate Cancer Molecular Diagnostics Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Prostate Cancer Molecular Diagnostics Market Size and Forecast (2016-2026)

8.3.7 Australia Prostate Cancer Molecular Diagnostics Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Prostate Cancer Molecular Diagnostics Revenue by Type (2016-2026)

9.2 South America Prostate Cancer Molecular Diagnostics Revenue by Application (2016-2026)

9.3 South America Prostate Cancer Molecular Diagnostics Market Size by Country

9.3.1 South America Prostate Cancer Molecular Diagnostics Revenue by Country (2016-2026)

9.3.2 Brazil Prostate Cancer Molecular Diagnostics Market Size and Forecast (2016-2026)

9.3.3 Argentina Prostate Cancer Molecular Diagnostics Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Prostate Cancer Molecular Diagnostics Revenue by Type (2016-2026)

10.2 Middle East & Africa Prostate Cancer Molecular Diagnostics Revenue by Application (2016-2026)

10.3 Middle East & Africa Prostate Cancer Molecular Diagnostics Market Size by Country

10.3.1 Middle East & Africa Prostate Cancer Molecular Diagnostics Revenue by Country (2016-2026)

10.3.2 Turkey Prostate Cancer Molecular Diagnostics Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Prostate Cancer Molecular Diagnostics Market Size and Forecast (2016-2026)

10.3.4 UAE Prostate Cancer Molecular Diagnostics Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Prostate Cancer Molecular Diagnostics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Prostate Cancer Molecular Diagnostics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Prostate Cancer Molecular Diagnostics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Prostate Cancer Molecular Diagnostics Revenue (USD Million) by Region (2016-2021)

Table 5. Global Prostate Cancer Molecular Diagnostics Revenue Market Share by Region (2021-2026)

Table 6. Qiagen Corporate Information, Head Office, and Major Competitors

Table 7. Qiagen Major Business

Table 8. Qiagen Prostate Cancer Molecular Diagnostics Product and Solutions

Table 9. Qiagen Prostate Cancer Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Foundationmedicine Corporate Information, Head Office, and Major Competitors

Table 11. Foundationmedicine Major Business

Table 12. Foundationmedicine Prostate Cancer Molecular Diagnostics Product and Solutions

Table 13. Foundationmedicine Prostate Cancer Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Genetech Corporate Information, Head Office, and Major Competitors

Table 15. Genetech Major Business

Table 16. Genetech Prostate Cancer Molecular Diagnostics Product and Solutions

Table 17. Genetech Prostate Cancer Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Gpmedical Corporate Information, Head Office, and Major Competitors

Table 19. Gpmedical Major Business

Table 20. Gpmedical Prostate Cancer Molecular Diagnostics Product and Solutions

Table 21. Gpmedical Prostate Cancer Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Premed Corporate Information, Head Office, and Major Competitors

Table 23. Premed Major Business

Table 24. Premed Prostate Cancer Molecular Diagnostics Product and Solutions

Table 25. Premed Prostate Cancer Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Berryoncology Corporate Information, Head Office, and Major Competitors

Table 27. Berryoncology Major Business

Table 28. Berryoncology Prostate Cancer Molecular Diagnostics Product and Solutions

Table 29. Berryoncology Prostate Cancer Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Gene+ Corporate Information, Head Office, and Major Competitors

Table 31. Gene+ Major Business

Table 32. Gene+ Prostate Cancer Molecular Diagnostics Product and Solutions

Table 33. Gene+ Prostate Cancer Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Annoroad Corporate Information, Head Office, and Major Competitors

Table 35. Annoroad Major Business

Table 36. Annoroad Prostate Cancer Molecular Diagnostics Product and Solutions

Table 37. Annoroad Prostate Cancer Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Topgen Corporate Information, Head Office, and Major Competitors

Table 39. Topgen Major Business

Table 40. Topgen Prostate Cancer Molecular Diagnostics Product and Solutions

Table 41. Topgen Prostate Cancer Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Geneis Corporate Information, Head Office, and Major Competitors

Table 43. Geneis Major Business

Table 44. Geneis Prostate Cancer Molecular Diagnostics Product and Solutions

Table 45. Geneis Prostate Cancer Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Global Prostate Cancer Molecular Diagnostics Revenue (USD Million) by Players (2019-2021)

Table 47. Global Prostate Cancer Molecular Diagnostics Revenue Share by Players (2019-2021)

Table 48. Breakdown of Prostate Cancer Molecular Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)

Table 49. Prostate Cancer Molecular Diagnostics Players Head Office, Products and Services Provided

Table 50. Prostate Cancer Molecular Diagnostics Mergers & Acquisitions in the Past Five Years

Table 51. Prostate Cancer Molecular Diagnostics New Entrants and Expansion Plans

Table 52. Global Prostate Cancer Molecular Diagnostics Revenue (USD Million) by Type (2016-2021)

Table 53. Global Prostate Cancer Molecular Diagnostics Revenue Share by Type (2016-2021)

Table 54. Global Prostate Cancer Molecular Diagnostics Revenue Forecast by Type (2021-2026)

Table 55. Global Prostate Cancer Molecular Diagnostics Revenue by Application (2016-2021)

Table 56. Global Prostate Cancer Molecular Diagnostics Revenue Forecast by Application (2021-2026)

Table 57. North America Prostate Cancer Molecular Diagnostics Revenue by Type (2016-2021) & (USD Million)

Table 58. North America Prostate Cancer Molecular Diagnostics Revenue by Type (2021-2026) & (USD Million)

Table 59. North America Prostate Cancer Molecular Diagnostics Revenue by Application (2016-2021) & (USD Million)

Table 60. North America Prostate Cancer Molecular Diagnostics Revenue by Application (2021-2026) & (USD Million)

Table 61. North America Prostate Cancer Molecular Diagnostics Revenue by Country (2016-2021) & (USD Million)

Table 62. North America Prostate Cancer Molecular Diagnostics Revenue by Country (2021-2026) & (USD Million)

Table 63. Europe Prostate Cancer Molecular Diagnostics Revenue by Type (2016-2021) & (USD Million)

Table 64. Europe Prostate Cancer Molecular Diagnostics Revenue by Type (2021-2026) & (USD Million)

Table 65. Europe Prostate Cancer Molecular Diagnostics Revenue by Application (2016-2021) & (USD Million)

Table 66. Europe Prostate Cancer Molecular Diagnostics Revenue by Application (2021-2026) & (USD Million)

Table 67. Europe Prostate Cancer Molecular Diagnostics Revenue by Country (2016-2021) & (USD Million)

Table 68. Europe Prostate Cancer Molecular Diagnostics Revenue by Country (2021-2026) & (USD Million)

Table 69. Asia-Pacific Prostate Cancer Molecular Diagnostics Revenue by Type (2016-2021) & (USD Million)

Table 70. Asia-Pacific Prostate Cancer Molecular Diagnostics Revenue by Type (2021-2026) & (USD Million)

Table 71. Asia-Pacific Prostate Cancer Molecular Diagnostics Revenue by Application (2016-2021) & (USD Million)

Table 72. Asia-Pacific Prostate Cancer Molecular Diagnostics Revenue by Application (2021-2026) & (USD Million)

Table 73. Asia-Pacific Prostate Cancer Molecular Diagnostics Revenue by Region (2016-2021) & (USD Million)

Table 74. Asia-Pacific Prostate Cancer Molecular Diagnostics Revenue by Region (2021-2026) & (USD Million)

Table 75. South America Prostate Cancer Molecular Diagnostics Revenue by Type (2016-2021) & (USD Million)

Table 76. South America Prostate Cancer Molecular Diagnostics Revenue by Type (2021-2026) & (USD Million)

Table 77. South America Prostate Cancer Molecular Diagnostics Revenue by Application (2016-2021) & (USD Million)

Table 78. South America Prostate Cancer Molecular Diagnostics Revenue by Application (2021-2026) & (USD Million)

Table 79. South America Prostate Cancer Molecular Diagnostics Revenue by Country (2016-2021) & (USD Million)

Table 80. South America Prostate Cancer Molecular Diagnostics Revenue by Country (2021-2026) & (USD Million)

Table 81. Middle East & Africa Prostate Cancer Molecular Diagnostics Revenue by Type (2016-2021) & (USD Million)

Table 82. Middle East & Africa Prostate Cancer Molecular Diagnostics Revenue by Type (2021-2026) & (USD Million)

Table 83. Middle East & Africa Prostate Cancer Molecular Diagnostics Revenue by Application (2016-2021) & (USD Million)

Table 84. Middle East & Africa Prostate Cancer Molecular Diagnostics Revenue by Application (2021-2026) & (USD Million)

Table 85. Middle East & Africa Prostate Cancer Molecular Diagnostics Revenue by Country (2016-2021) & (USD Million)

Table 86. Middle East & Africa Prostate Cancer Molecular Diagnostics Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Prostate Cancer Molecular Diagnostics Picture

Figure 2. Global Prostate Cancer Molecular Diagnostics Revenue Market Share by Type in 2020

Figure 3. PCR

Figure 4. FISH

Figure 5. DNA Sequencing

Figure 6. Gene Chip

Figure 7. Prostate Cancer Molecular Diagnostics Revenue Market Share by Application in 2020

Figure 8. Clinical Diagnosis Picture

Figure 9. Drug Screening Picture

Figure 10. Research Picture

Figure 11. Global Prostate Cancer Molecular Diagnostics Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 12. Global Prostate Cancer Molecular Diagnostics Revenue and Forecast (2016-2026) & (USD Million)

Figure 13. Global Prostate Cancer Molecular Diagnostics Revenue Market Share by Region (2016-2026)

Figure 14. Global Prostate Cancer Molecular Diagnostics Revenue Market Share by Region in 2020

Figure 15. North America Prostate Cancer Molecular Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. Europe Prostate Cancer Molecular Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Asia-Pacific Prostate Cancer Molecular Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. South America Prostate Cancer Molecular Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. Middle East and Africa Prostate Cancer Molecular Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Prostate Cancer Molecular Diagnostics Market Drivers

Figure 21. Prostate Cancer Molecular Diagnostics Market Restraints

Figure 22. Prostate Cancer Molecular Diagnostics Market Trends

Figure 23. Qiagen Recent Developments and Future Plans

Figure 24. Foundationmedicine Recent Developments and Future Plans

Figure 25. Genetech Recent Developments and Future Plans

Figure 26. Gpmedical Recent Developments and Future Plans

Figure 27. Premed Recent Developments and Future Plans

Figure 28. Berryoncology Recent Developments and Future Plans

Figure 29. Gene+ Recent Developments and Future Plans

Figure 30. Annoroad Recent Developments and Future Plans

Figure 31. Topgen Recent Developments and Future Plans

Figure 32. Geneis Recent Developments and Future Plans

Figure 33. Global Prostate Cancer Molecular Diagnostics Revenue Share by Players in 2020

Figure 34. Prostate Cancer Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 35. Global Top 3 Players Prostate Cancer Molecular Diagnostics Revenue Market Share in 2020

Figure 36. Global Top 10 Players Prostate Cancer Molecular Diagnostics Revenue Market Share in 2020

Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 38. Global Prostate Cancer Molecular Diagnostics Revenue Share by Type in 2020

Figure 39. Global Prostate Cancer Molecular Diagnostics Market Share Forecast by Type (2021-2026)

Figure 40. Global Prostate Cancer Molecular Diagnostics Revenue Share by Application in 2020

Figure 41. Global Prostate Cancer Molecular Diagnostics Market Share Forecast by Application (2021-2026)

Figure 42. North America Prostate Cancer Molecular Diagnostics Sales Market Share by Type (2016-2026)

Figure 43. North America Prostate Cancer Molecular Diagnostics Sales Market Share by Application (2016-2026)

Figure 44. North America Prostate Cancer Molecular Diagnostics Revenue Market Share by Country (2016-2026)

Figure 45. United States Prostate Cancer Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 46. Canada Prostate Cancer Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 47. Mexico Prostate Cancer Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 48. Europe Prostate Cancer Molecular Diagnostics Sales Market Share by Type (2016-2026)

Figure 49. Europe Prostate Cancer Molecular Diagnostics Sales Market Share by Application (2016-2026)

Figure 50. Europe Prostate Cancer Molecular Diagnostics Revenue Market Share by Country (2016-2026)

Figure 51. Germany Prostate Cancer Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. France Prostate Cancer Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 53. United Kingdom Prostate Cancer Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. Russia Prostate Cancer Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. Italy Prostate Cancer Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. Asia-Pacific Prostate Cancer Molecular Diagnostics Sales Market Share by Type (2016-2026)

Figure 57. Asia-Pacific Prostate Cancer Molecular Diagnostics Sales Market Share by Application (2016-2026)

Figure 58. Asia-Pacific Prostate Cancer Molecular Diagnostics Revenue Market Share by Region (2016-2026)

Figure 59. China Prostate Cancer Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Japan Prostate Cancer Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. South Korea Prostate Cancer Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. India Prostate Cancer Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Southeast Asia Prostate Cancer Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. Australia Prostate Cancer Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. South America Prostate Cancer Molecular Diagnostics Sales Market Share by Type (2016-2026)

Figure 66. South America Prostate Cancer Molecular Diagnostics Sales Market Share by Application (2016-2026)

Figure 67. South America Prostate Cancer Molecular Diagnostics Revenue Market Share by Country (2016-2026)

Figure 68. Brazil Prostate Cancer Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Argentina Prostate Cancer Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. Middle East and Africa Prostate Cancer Molecular Diagnostics Sales Market Share by Type (2016-2026)

Figure 71. Middle East and Africa Prostate Cancer Molecular Diagnostics Sales Market Share by Application (2016-2026)

Figure 72. Middle East and Africa Prostate Cancer Molecular Diagnostics Revenue Market Share by Country (2016-2026)

Figure 73. Turkey Prostate Cancer Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. Saudi Arabia Prostate Cancer Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. UAE Prostate Cancer Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Methodology

Figure 77. Research Process and Data Source